Xingjie Peng

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Effects of Accelerated Intermittent Theta Burst Stimulation Targeting the Superior Frontal Gyrus on Cognitive Function in Patients With Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical Trial.

Effects of Accelerated Intermittent Theta Burst Stimulation Targeting the Superior Frontal Gyrus on Cognitive Function in Patients With Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical Trial.

Journal: Biological psychiatry

Published: February 03, 2025

Subgroups of cognitive impairments in schizophrenia characterized by executive function and their morphological features: a latent profile analysis study.

Subgroups of cognitive impairments in schizophrenia characterized by executive function and their morphological features: a latent profile analysis study.

Journal: BMC medicine

Published: May 31, 2024

Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses.

Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses.

Journal: European archives of psychiatry and clinical neuroscience

Published: November 08, 2023

The effect of continuous theta burst stimulation on antipsychotic-induced weight gain in first-episode drug-naive individuals with schizophrenia: a double-blind, randomized, sham-controlled feasibility trial.

The effect of continuous theta burst stimulation on antipsychotic-induced weight gain in first-episode drug-naive individuals with schizophrenia: a double-blind, randomized, sham-controlled feasibility trial.

Journal: Translational psychiatry

Published: May 15, 2023

Prefrontal cortical dopamine deficit may cause impaired glucose metabolism in schizophrenia.

Prefrontal cortical dopamine deficit may cause impaired glucose metabolism in schizophrenia.

Journal: Translational psychiatry

Published: May 09, 2023

Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.

Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.

Journal: Psychiatry research

Published: November 23, 2022

Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials.

Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials.

Journal: Schizophrenia bulletin

Published: May 15, 2022

The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial.

The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial.

Journal: Translational psychiatry

Published: March 14, 2022

PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients.

PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients.

Journal: Psychopharmacology

Published: August 30, 2021

Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial.

Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial.

Journal: Trials

Published: July 22, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026